LXRβ emerges as a promising target for depression and anxiety treatments

In a state-of-the-art Bench to Bedside review published in the journal Brain Medicine (Genomic Press), researchers Dr. Xiaoyu Song and Professor Jan-Åke Gustafsson from the University of Houston and Karolinska Institutet (Sweden) shed light on the therapeutic potential of liver X receptor beta (LXRβ) in treating depression and anxiety.

Health economist marks up UnitedHealth CEO’s Senate hearing on the Change Healthcare cyberattack

For lawmakers on both sides of the aisle, Wednesday’s congressional hearings about the Change Healthcare cyberattack turned into an airing of grievances against Change’s parent

May 2, 2024

Plastic Glove, Scissors Solve Problem in Single-Lung Ventilation

SAN FRANCISCO — Chinese researchers reported a simple but clever solution to the problem of how to facilitate non-dependent lung collapse during single-lung ventilation, which

October 18, 2023

Depression’s heavy toll: Unraveling its impact on overall health in US adults

Depression in US adults found to significantly raise risks of death, particularly from cardiovascular ailments. Increased awareness and treatment can mitigate impacts.

October 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.